QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 191 filers reported holding QIAGEN NV in Q4 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $15,126,000 | -6.3% | 539,837 | -8.2% | 0.01% | +10.0% |
Q3 2016 | $16,139,000 | +56.5% | 588,163 | +24.4% | 0.01% | +25.0% |
Q2 2016 | $10,313,000 | -2.8% | 472,870 | -0.5% | 0.01% | 0.0% |
Q1 2016 | $10,615,000 | -41.4% | 475,149 | -27.4% | 0.01% | -42.9% |
Q4 2015 | $18,105,000 | +2.2% | 654,800 | -4.7% | 0.01% | 0.0% |
Q3 2015 | $17,718,000 | -14.4% | 686,737 | -17.7% | 0.01% | -6.7% |
Q2 2015 | $20,695,000 | -18.7% | 834,831 | -17.3% | 0.02% | -16.7% |
Q1 2015 | $25,449,000 | +12.1% | 1,009,873 | +4.3% | 0.02% | +12.5% |
Q4 2014 | $22,710,000 | +23.2% | 968,037 | +19.6% | 0.02% | +23.1% |
Q3 2014 | $18,432,000 | +14.8% | 809,490 | +23.3% | 0.01% | +18.2% |
Q2 2014 | $16,052,000 | +14.9% | 656,522 | -0.8% | 0.01% | +10.0% |
Q1 2014 | $13,965,000 | -12.4% | 662,143 | -1.1% | 0.01% | -9.1% |
Q4 2013 | $15,936,000 | +8.6% | 669,303 | -2.4% | 0.01% | 0.0% |
Q3 2013 | $14,677,000 | +3.5% | 685,835 | -3.7% | 0.01% | -8.3% |
Q2 2013 | $14,185,000 | – | 712,467 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hardman Johnston Global Advisors LLC | 6,178,402 | $170,833,000 | 11.32% |
Tikvah Management LLC | 369,425 | $10,215,000 | 5.35% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 360,000 | $9,954,000 | 3.36% |
Opus Point Partners Management, LLC | 160,000 | $4,424,000 | 2.92% |
Exane Asset Management | 106,238 | $2,910,304,000 | 1.76% |
Douglas C. Lane & Associates, Inc. | 1,918,338 | $53,042,000 | 1.44% |
Granahan Investment Management | 1,051,000 | $29,060,000 | 1.00% |
CRAMER ROSENTHAL MCGLYNN LLC | 2,285,569 | $63,196,000 | 0.95% |
Sivik Global Healthcare LLC | 70,000 | $1,936,000 | 0.92% |
PURA VIDA INVESTMENTS, LLC | 78,668 | $2,175,000 | 0.92% |